Evidence map›Paper›PMID 17287262›Full record

ArticleJournal of virology2007

Fusogenic variants of a noncytopathic paramyxovirus.

Shaguna Seth, Ioanna Skountzou, Kim M Gernert, Richard W Compans

Abstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shaguna SethDepartment of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, USA.
Ioanna Skountzou
Kim M Gernert
Richard W Compans
Emory University · US

Funding

Regulation of Viral Membrane FusionR01AI054337 · NIAID · EMORY UNIVERSITY · PI COMPANS, RICHARD W · 2004 to 2008
$1.1M
Regulation of Viral Membrane FusionR21AI054337 · NIAID · EMORY UNIVERSITY · PI COMPANS, RICHARD W · 2003 to 2003
$230k
NIAID NIH HHS AI 54337NIAID NIH HHS R01 AI054337NIAID NIH HHS R21 AI054337
6 · The paper itself

Abstract

SER virus is a type 5 parainfluenza virus that does not exhibit syncytium formation, in contrast to most other paramyxoviruses. This property has been attributed, at least in part, to the presence of an extension of the cytoplasmic tail (CT) of the SER F protein, as truncations or mutations of this region resulted in enhanced fusion. In this study we used repeated passage to select for mutant SER viruses, which were found to be fusogenic. The mutant viruses replicated at levels comparable to or higher than the wild-type SER virus and caused plaque formation, in contrast to the wild-type virus which does not form plaques. The mutants differed strikingly in their plaque sizes. The F genes of mutant viruses were cloned and sequenced and shared some mutations, including a proline-to-leucine change at position 22 and an isoleucine-to-leucine substitution at position 191; other changes that were specific to each mutant were also found. The HN proteins of mutant viruses also showed mutations spanning the length of the protein whereas the M protein showed a consistent mutation, threonine to isoleucine, at position 129. The structure of the F protein was used to identify residues involved in the mutant phenotypes in terms of their location and proximity to heptad repeat domains.

Indexed as

Cell FusionCytopathogenic Effect, ViralAmino Acid SubstitutionDNA Mutational AnalysisGiant CellsHN ProteinModels, MolecularMutationParamyxoviridaeSequence Analysis, DNAViral Fusion ProteinsViral Plaque AssayVirus ReplicationHN ProteinViral Fusion Proteins

Identifiers

PMID17287262
PMCPMC1866114
OpenAlexW2099673779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.